L

M

LICHTNER , Miriam

Last name: LICHTNER

First name: Miriam

2020 (v1)

Publication

Metadata-only

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

Perrone, Francesco Piccirillo, Maria Carmela Ascierto, Paolo Antonio

BackgroundTocilizumab blocks pro-inflammatory activity of interleukin-6 (IL-6), involved in pathogenesis of pneumonia the most frequent cause of death in COVID-19 patients.MethodsA multicenter, single-arm, hypothesis-driven trial was planned, according to a phase 2 design, to study the effect of tocilizumab on lethality rates at 14 and 30 days...

Uploaded on: March 25, 2023
2015 (v1)

Publication

Metadata-only

Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus

Mussini, Cristina Lorenzini, Patrizia Puoti, Massimo

Objective: To evaluate the Fibrosis (FIB)-4 index as a predictor of major liver-related events (LRE) and liver-related death (LRD) in human immunodeficiency virus (HIV) type-1 patients initiating combination antiretroviral therapy (cART). Design: Retrospective analysis of a prospective cohort study. Setting: Italian HIV care centers...

Uploaded on: May 13, 2023